Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06844045 · ClinicalTrials.gov registry record · NA
Point of Care STI Testing
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 6,460
- Enrollment target
NCT06844045 is a NA study that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 6,460 participants.
The verdict
NCT06844045, a NA study, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 6,460 participants
- Enrollment target
Study Summary
The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.
Interventions
- BEHAVIORAL Gonorrhea/chlamydia Point-of-Care Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,460 participants |
| Start Date | 2026-02-24 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06844045
The ClinicalTrials.gov registry entry for NCT06844045 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 6,460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gonorrhea/chlamydia Point-of-Care Testing is the first listed.
NCT06844045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06844045 about?
NCT06844045 is a clinical study titled "Point of Care STI Testing". The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasi...
What is the current status of trial NCT06844045?
This trial is currently recruiting. It is a NA study. The enrollment target is 6,460 participants. The study started on 2026-02-24. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT06844045?
The interventions under investigation include: Gonorrhea/chlamydia Point-of-Care Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06844045?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.